New cholesterol guidelines released by the American Heart Association

March 13, 2026 - 19:39

The American Heart Association has issued updated recommendations for managing cholesterol, marking a significant shift in preventive cardiovascular care. A central update advises physicians to incorporate testing for two specific blood biomarkers when evaluating a patient's risk for heart disease.

These biomarkers, lipoprotein(a) and apolipoprotein B, provide a more detailed picture of cardiovascular risk beyond traditional "bad" LDL cholesterol readings. Elevated levels of either substance have been strongly linked to a higher likelihood of heart attacks and strokes, even in individuals with otherwise acceptable LDL levels. The new guidance suggests that identifying these risks earlier allows for more personalized and potentially aggressive intervention strategies.

The recommendations continue to emphasize the importance of lifestyle modifications as a first line of defense, including a heart-healthy diet, regular exercise, and smoking cessation. For patients at higher risk, statin medications remain a cornerstone of treatment. However, by formally adding these two tests to the assessment toolkit, the guidelines aim to refine risk calculation and help doctors tailor treatment plans more effectively for millions of adults, aiming to prevent cardiovascular events before they occur.